Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Background A pilot study (NCT00316563) to determine if delta-9-tetrahydrocannabinol (THC) can improve taste and smell (chemosensory) perception as well as appetite, caloric intake, and quality of life (QOL) for cancer patients with chemosensory alterations. Patients and methods Adult advanced cancer patients, with poor appetite and chemosensory alterations, were recruited from two sites and randomized in a double-blinded manner to receive either THC (2.5 mg, Marinol(®); Solvay Pharma Inc., n = 24) or placebo oral capsules (n = 22) twice daily for 18 days. Twenty-one patients completed the trial. At baseline and posttreatment, patients completed a panel of patient-reported outcomes: Taste and Smell Survey, 3-day food record, appetite and macronutrient preference assessments, QOL questionnaire, and an interview. Results THC and placebo groups were comparable at baseline. Compared with placebo, THC-treated patients reported improved (P = 0.026) and enhanced (P Conclusions THC may be useful in the palliation of chemosensory alterations and to improve food enjoyment for cancer patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Steel, R. G. D., & Torrie, J. H. (1980) · Andalas University Repository (Andalas University) · Cited by 17,062
Principles and Procedures of Statistics: A Biometrical Approach
Steel, R. G. D., & Torrie, J. H. (1980) · Andalas University Repository (Andalas University) · Cited by 15,510
Principles and Procedures of Statistics: A Biometrical Approach.
Calinski, T., Steel, R. G. D., & Torrie, J. H. (1981) · Biometrics · doi:10.2307/2530180 · Cited by 4,337
Bruera, E., Kuehn, N., Miller, M. J., Selmser, P., & Macmillan, K. (1991) · Journal of Palliative Care · doi:10.1177/082585979100700202 · Cited by 2,683 · cited 2×
“The 11-point Edmonton Symptom Assessment System [33] was used to assess nausea.”
MethodThe CAGE Questionnaire: Validation of a New Alcoholism Screening Instrument
MAYFIELD, D., MCLEOD, G., & HALL, P. (1974) · American Journal of Psychiatry · doi:10.1176/ajp.131.10.1121 · Cited by 2,249 · cited 1×
“exclusion criteria Exclusion criteria included receiving enteral or parenteral nutrition; allergies or sensitivity to THC and/or sesame seed oil; history of substance abuse (determined by review of patients’ medical records, alcohol abuse was often also assessed by CAGE questionnaire [24]) or psychotic episodes (e.”
BackgroundDistribution of cannabinoid receptors in the central and peripheral nervous system
Mackie, K. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-26573-2_10 · Cited by 744 · cited 2×
“Improved sleep may be due to the presence of CB1r in the basal forebrain [20] or related to increased relaxation noted in various populations [7, 44].”
BackgroundThe Prognostic Significance of Patient-Reported Outcomes in Cancer Clinical Trials
Gotay, C. C., Kawamoto, C. T., Bottomley, A., & Efficace, F. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.3439 · Cited by 644
Jatoi, A., Windschitl, H. E., Loprinzi, C. L., Sloan, J. A., Dakhil, S. R., Mailliard, J. A., Pundaleeka, S., Kardinal, C. G., Fitch, T. R., Krook, J. E., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.2.567 · Cited by 543 · cited 3×
“[6] reported THC to stimulate appetite in 50% of patients.”
BackgroundInfluentialDronabinol as a treatment for anorexia associated with weight loss in patients with AIDS
Beal, J. E., Olson, R., Laubenstein, L., Morales, J. O., Bellman, P., Yangco, B., Lefkowitz, L., Plasse, T. F., & Shepard, K. V. (1995) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(94)00117-4 · Cited by 504 · cited 2×
“THC increases appetite via endocannabinoid receptors (CB1r); appetite stimulation is documented in animals [9, 10] and in healthy human [11, 12] and acquired immunodeficiency syndrome (AIDS) populations [13, 14].”
BackgroundStrasser, F., Luftner, D., Possinger, K., Ernst, G., Ruhstaller, T., Meissner, W., Ko, Y.-D., Schnelle, M., Reif, M., & Cerny, T. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.1847 · Cited by 413
Armijo-Olivo, S., Warren, S., & Magee, D. (2009) · Physical Therapy Reviews · doi:10.1179/174328809x405928 · Cited by 361 · cited 1×
“statistical analyses Statistical analyses were performed on a per protocol analysis basis [35] using SAS (Statistical Analysis System for Windows, Cary, NC) [36].”
MethodEndogenous cannabinoid system as a modulator of food intake
Cota, D., Marsicano, G., Lutz, B., Vicennati, V, Stalla, G. K., Pasquali, R., & Pagotto, U. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802250 · Cited by 315 · cited 2×
“THC increases appetite via endocannabinoid receptors (CB1r); appetite stimulation is documented in animals [9, 10] and in healthy human [11, 12] and acquired immunodeficiency syndrome (AIDS) populations [13, 14].”
BackgroundSallan, S. E., Cronin, C., Zelen, M., & Zinberg, N. E. (1980) · New England Journal of Medicine · doi:10.1056/nejm198001173020302 · Cited by 261 · cited 1×
“Of seven studies [2–8], two investigated THC as an antiemetic with the assessment of appetite as a side effect [2, 3], two were uncontrolled [4, 5], and one of two placebo-controlled studies used weight gain as an outcome following just 1 week of treatment [7].”
Foltin, R. W., Fischman, M. W., & Byrne, M. F. (1988) · Appetite · doi:10.1016/s0195-6663(88)80017-5 · Cited by 256 · cited 2×
“THC increases appetite via endocannabinoid receptors (CB1r); appetite stimulation is documented in animals [9, 10] and in healthy human [11, 12] and acquired immunodeficiency syndrome (AIDS) populations [13, 14].”
BackgroundHyperphagia in pre-fed rats following oral δ9-THC
Williams, C. M., Rogers, P. J., & Kirkham, T. C. (1998) · Physiology & Behavior · doi:10.1016/s0031-9384(98)00170-x · Cited by 256
Steinbach, S., Hummel, T., Böhner, C., Berktold, S., Hundt, W., Kriner, M., Heinrich, P., Sommer, H., Hanusch, C., Prechtl, A., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.2690 · Cited by 245 · cited 1×
“[40] have recently used selfreported chemosensory perception to comprehensively describe taste and smell changes experienced by cancer patients.”
BackgroundHutton, J. L., Baracos, V. E., & Wismer, W. V. (2007) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2006.07.017 · Cited by 238 · cited 15×
“QOL was assessed with the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire [32].”
BackgroundInfluentialSelf-citationFreund, R. J., & Wilson, W. J. (1993) · Cited by 230
Recent clinical experience with dronabinol
Plasse, T. F., Gorter, R. W., Krasnow, S. H., Lane, M., Shepard, K. V., & Wadleigh, R. G. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90385-f · Cited by 224 · cited 1×
“Of seven studies [2–8], two investigated THC as an antiemetic with the assessment of appetite as a side effect [2, 3], two were uncontrolled [4, 5], and one of two placebo-controlled studies used weight gain as an outcome following just 1 week of treatment [7].”
A World Health Organizadon Demonstration Project, Nelson, K., Walsh, D., Deeter, P., & Sheehan, F. (1994) · Journal of Palliative Care · doi:10.1177/082585979401000105 · Cited by 215 · cited 3×
“[4] showed promising THC appetite stimulation in cancer and 6 of 18 patients opted to remain on THC treatment for improved appetite and food intake [46].”
BackgroundSelf-reported taste and smell changes during cancer chemotherapy
Bernhardson, B.-M., Tishelman, C., & Rutqvist, L. E. (2008) · Supportive Care in Cancer · doi:10.1007/s00520-007-0319-7 · Cited by 211
Understanding and Managing Cancer Cachexia
MacDonald, N., Easson, A. M., Mazurak, V. C., Dunn, G. P., & Baracos, V. E. (2003) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(03)00382-x · Cited by 207 · cited 1×
“Anorexia and weight loss contribute to functional loss, decreased survival, and poor quality of life (QOL) of advanced cancer patients [1].”
BackgroundSelf-citationRibaudo, J. M., Cella, D., Hahn, E. A., Lloyd, S. R., Tchekmedyian, N. S., Roenn, J. V., & Leslie, W. T. (2000) · Quality of Life Research · doi:10.1023/a:1016670403148 · Cited by 202 · cited 1×
“QOL was assessed with the Functional Assessment of Anorexia/Cachexia Therapy (FAACT) questionnaire [32].”
MethodTaste changes experienced by patients receiving chemotherapy.
Wickham, R. S., Rehwaldt, M., Kefer, C., Shott, S., Abbas, K., Glynn-Tucker, E., Potter, C., & Blendowski, C. (1999) · PubMed · Cited by 194
Food choice and intake: the human factor
Mela, D. J. (1999) · Proceedings of the Nutrition Society · doi:10.1017/s0029665199000683 · Cited by 193 · cited 1×
“Here, improved quality of sleep and relaxation may have increased appetite and improved chemosensory perception, encouraging a positive outlook on food [45].”
BackgroundCannabis use for chronic non-cancer pain: results of a prospective survey
Ware, M. A., Doyle, C. R., Woods, R., Lynch, M. E., & Clark, A. J. (2003) · Pain · doi:10.1016/s0304-3959(02)00400-1 · Cited by 185 · cited 2×
“Quality of sleep and relaxation were more frequently reported to be ‘pleasant’ by THC-treated patients compared with placebo on the Side Effect Survey (Table 3).”
BackgroundDronabinol and Marijuana in HIV-Positive Marijuana Smokers: Caloric Intake, Mood, and Sleep
Haney, M., Gunderson, E. W., Rabkin, J., Hart, C. L., Vosburg, S. K., Comer, S. D., & Foltin, R. W. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31811ed205 · Cited by 184 · cited 3×
“THC increases appetite via endocannabinoid receptors (CB1r); appetite stimulation is documented in animals [9, 10] and in healthy human [11, 12] and acquired immunodeficiency syndrome (AIDS) populations [13, 14].”
BackgroundDevelopment and testing of a labeled magnitude scale of perceived satiety
Cardello, A. V., Schutz, H. G., Lesher, L. L., & Merrill, E. P. (2004) · Appetite · doi:10.1016/j.appet.2004.05.007 · Cited by 175
Influence of taste disorders on dietary behaviors in cancer patients under chemotherapy
Sánchez-Lara, K., Sosa-Sánchez, R., Green-Renner, D., Rodríguez, C., Laviano, A., Motola‐Kuba, D., & Arrieta, O. G. (2010) · Nutrition Journal · doi:10.1186/1475-2891-9-15 · Cited by 147 · cited 1×
“One consideration for future trials will be the situation of therapy for taste and smell alterations within the disease trajectory, as these problems have been characterized both during first-line therapy in treatment naı̈ve patients [47] as well as in advanced stage patients with progressive disease who have received…”
BackgroundEffects of Marihuana on the Solution of Anagrams, Memory and Appetite
Abel, E. L. (1971) · Nature · doi:10.1038/231260b0 · Cited by 119 · cited 2×
“THC increases appetite via endocannabinoid receptors (CB1r); appetite stimulation is documented in animals [9, 10] and in healthy human [11, 12] and acquired immunodeficiency syndrome (AIDS) populations [13, 14].”
BackgroundTaste and smell complaints in HIV-infected patients
Heald, A. E., Pieper, C. F., & Schiffman, S. S. (1998) · AIDS · doi:10.1097/00002030-199813000-00015 · Cited by 113 · cited 4×
“Safety and tolerability were also assessed. patients and methods This two-centre (Cross Cancer Institute, Edmonton, Alberta and Jewish General Hospital, Montreal, Quebec), phase II, randomized, double-blind, placebo-controlled 22-day pilot study (NCT00316563) was approved by Health Canada and the Research Ethics Board…”
BackgroundMethodInfluentialAMELIORATION OF CANCER CHEMOTHERAPY‐INDUCED NAUSEA AND VOMITING BY DELTA‐9‐TETRAHYDRO‐CANNABINOL
Ekert, H., Waters, K. D., Jurk, I. H., Mobilia, J., & Loughnan, P. (1979) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1979.tb127271.x · Cited by 97 · cited 1×
“Of seven studies [2–8], two investigated THC as an antiemetic with the assessment of appetite as a side effect [2, 3], two were uncontrolled [4, 5], and one of two placebo-controlled studies used weight gain as an outcome following just 1 week of treatment [7].”
BackgroundHuman Studies of Cannabinoids and Medicinal Cannabis
Robson, P. (2005) · Springer eBooks · doi:10.1007/3-540-26573-2_25 · Cited by 94 · cited 1×
“THC may palliate an array of symptoms: chemosensory alterations, food enjoyment, pain, depression, anxiety, poor quality of sleep, and inflammation [43].”
BackgroundShragge, J. E., Wismer, W. V., Olson, K. L., & Baracos, V. E. (2007) · Palliative Medicine · doi:10.1177/0269216307077172 · Cited by 76 · cited 1×
“Patients frequently report loss of food ideation and desire to eat [17, 18].”
BackgroundSelf-citationCannabinoid action in the olfactory epithelium
Czesnik, D., Schild, D., Kuduz, J., & Manzini, I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609067104 · Cited by 72 · cited 1×
“CB1r are located in reward-related areas of the brain [20] and in the olfactory epithelium and bulb [20, 21] and are involved in peripheral odor processing [21] and potentially taste function [22].”
BackgroundOike, H., Wakamori, M., Mori, Y., Nakanishi, H., Taguchi, R., Misaka, T., Matsumoto, I., & Abe, K. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.07.005 · Cited by 71 · cited 1×
“CB1r are located in reward-related areas of the brain [20] and in the olfactory epithelium and bulb [20, 21] and are involved in peripheral odor processing [21] and potentially taste function [22].”
BackgroundComparison of three consecutive-day and three random-day records of dietary intake
Larkin, F. A., Metzner, H. L., & Guire, K. E. (1991) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(21)01430-9 · Cited by 68 · cited 1×
“A 3-day dietary record [31] was used to estimate total calories and macronutrient intake (Food Processor II Nutrient Analysis Program; Esha Research, Salem, OR).”
MethodChemosensory alterations and cancer therapies.
Bartoshuk, L. M. (1990) · PubMed · Cited by 66
Patient-Related Barriers to Fatigue Communication in Cancer Patients Receiving Active Treatment
Shun, S., Lai, Y., & Hsiao, F. (2009) · The Oncologist · doi:10.1634/theoncologist.2009-0048 · Cited by 57
Jarrett, M. M., Scantlebury, J., & Parker, L. A. (2006) · Physiology & Behavior · doi:10.1016/j.physbeh.2006.10.003 · Cited by 46
Mattes, R. D., Shaw, L. M. J., & Engelman, K. (1994) · Chemical Senses · doi:10.1093/chemse/19.2.125 · Cited by 36 · cited 1×
“As absorption of oral THC varies greatly between individuals [25, 48], and given the controversy surrounding the appropriate dose in cancer, future trials may allow patients to titrate their dose or compare different dose levels.”
BackgroundWalsh, D., Kirkova, J., & Davis, M. P. (2005) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2005.11.007 · Cited by 31 · cited 1×
“[4] showed promising THC appetite stimulation in cancer and 6 of 18 patients opted to remain on THC treatment for improved appetite and food intake [46].”
BackgroundMOTIVES FOR DRUG USE AMONG LIGHT AND HEAVY USERS
Nail, C. R. L., Gunderson, E. K. E., & Kolb, D. (1974) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-197408000-00007 · Cited by 27 · cited 1×
“Our findings parallel earlier results of enhanced sensory perception and improved food enjoyment among healthy marijuana users [41, 42].”
ResultPsychologic effects of oral delta-9-tetrahydrocannabinol in advanced cancer patients
Noyes, R., Brunk, S. F., Avery, D., & Canter, A. (1976) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(76)80008-9 · Cited by 13
Modification and validation of a Macronutrient Preference Checklist for use in North America
Brisbois, T. D., McIsaac, T. M., Goonewardene, L. A., & Wismer, W. V. (2009) · Appetite · doi:10.1016/j.appet.2009.09.013 · Cited by 13 · cited 5×
“SLIM and MPC premeal scores were averaged for an overall day score.”
MethodInfluentialSelf-citationSubjective Benefits and Drawbacks of Marihuana and Alcohol
Roth, W. T., Tinklenberg, J. R., & Kopell, B. S. (1976) · Springer eBooks · doi:10.1007/978-1-4613-4286-1_19 · Cited by 2 · cited 2×
“Our findings parallel earlier results of enhanced sensory perception and improved food enjoyment among healthy marijuana users [41, 42].”
Result
Research works printed but not linked: 1
- Unimed. Marinol (Dronabinol) Capsules. In Solvay Pharmaceuticals, Inc., Edition 2003
Cited by
ESPEN guidelines on nutrition in cancer patients
Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., Bozzetti, F., Fearon, K., Hütterer, E., Isenring, E., Kaasa, S., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2016.07.015 · Cited by 3,114
“5 mg bid) for 18 days resulted in improved chemosensory perception, better taste perception of foods, and improved pre-meal appetite compared to placebo [233].”
BackgroundSelf-citationESPEN practical guideline: Clinical Nutrition in cancer
Muscaritoli, M., Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., Bozzetti, F., Hütterer, E., Isenring, E., Kaasa, S., et al. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.02.005 · Cited by 1,702
“5 mg bid) for 18 days resulted in improved chemosensory perception, better taste perception of foods, and improved pre-meal appetite compared to placebo [69].”
BackgroundSelf-citationESPEN practical guideline: Clinical nutrition in surgery
Weimann, A., Braga, M., Carli, F., Higashiguchi, T., Hübner, M., Klek, S., Laviano, A., Ljungqvist, O., Lobo, D. N., Martindale, R. G., et al. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.03.031 · Cited by 1,173
Greenlee, H., DuPont‐Reyes, M. J., Balneaves, L. G., Carlson, L. E., Cohen, M. R., Deng, G., Johnson, J. A., Mumber, M., Seely, D., Zick, S. M., et al. (2017) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21397 · Cited by 768
Oral complications of cancer and cancer therapy: From cancer treatment to survivorship
Epstein, J. B., Thariat, J., Bensadoun, R., Barasch, A., Murphy, B. A., Kolnick, L., Popplewell, L., & Maghami, E. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21157 · Cited by 518
Metadata
- Authors
- Brisbois, T. D., de Kock, I. H., Watanabe, S. M., Mirhosseini, M., Lamoureux, D. C., Chasen, M., MacDonald, N., Baracos, V. E., & Wismer, W. V.
- Affiliations
- University of Alberta (CA)
- University of Ottawa (CA)
- McGill University (CA)
- Corresponding author
- Wismer, W.V.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2011-09
- Volume
- 22
- Issue
- 9
- Pages
- 2086-2093
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2147927085
- Cited by
- 246
- References
- 45
- Citations by year
- 2026: 7 · 2025: 16 · 2024: 22 · 2023: 25 · 2022: 32 · 2021: 29 · 2020: 17 · 2019: 18 · 2018: 17 · 2017: 14 · 2016: 16 · 2015: 8 · 2014: 9 · 2013: 5 · 2012: 6
- FWCI
- 5.62
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 3004 d)
- Locations
- Annals of Oncology (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Canadian
- Institutes of Health Research
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Sensory Systems › Olfactory and Sensory Function Studies
- Health Sciences › Medicine › Surgery › Nausea and vomiting management
- Keywords
- delta-9-tetrahydrocannabinol, Marinol, cancer patients, appetite, energy intake, quality of life, food enjoyment, palliative care, sleep quality, macronutrient preference
- MeSH terms
- Aged, Double-Blind Method, Female, Humans, Male, Neoplasms, Palliative Care, Pilot Projects, Placebos, Quality of Life, Dronabinol, Olfactory Perception, Taste Perception
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.